The Influence of Glass Transition Temperature of PMMA-Based Nanoparticles on the Release Profile of Praziquantel as a Strategy for Controlling Drug Release
ACS Applied Nano Materials · 09.02.2024 · 7 (3) · 2417-2429
DOI: 10.1021/acsanm.3c06099 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 18.01.2024. Verfasst von Lys Hamond Regua Mangia und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Minist??rio da Ci??ncia, Tecnologia e Inova????o, Funda????o Carlos Chagas Filho de Amparo ?? Pesquisa do Estado do Rio de Janeiro, Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Minist??rio da Ci??ncia, Tecnologia e Inova????o
- Funda????o Carlos Chagas Filho de Amparo ?? Pesquisa do Estado do Rio de Janeiro
- Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior
Zitieren
APA
Mangia, L. H. R., Yamashita, F., Guindani, C., Ferraz, H. C., & Pinto, J. C. (2024). The Influence of Glass Transition Temperature of PMMA-Based Nanoparticles on the Release Profile of Praziquantel as a Strategy for Controlling Drug Release. ACS Applied Nano Materials, 7(3), 2417-2429. https://doi.org/10.1021/acsanm.3c06099
Vancouver
Mangia LHR, Yamashita F, Guindani C, Ferraz HC, Pinto JC. The Influence of Glass Transition Temperature of PMMA-Based Nanoparticles on the Release Profile of Praziquantel as a Strategy for Controlling Drug Release. ACS Applied Nano Materials. 2024;7(3):2417-2429. doi:10.1021/acsanm.3c06099
BibTeX
@article{Mangia2024,
author = {Mangia, Lys Hamond Regua and Yamashita, Flávia and Guindani, Camila and Ferraz, Helen Conceição and Pinto, José Carlos},
title = {The Influence of Glass Transition Temperature of PMMA-Based Nanoparticles on the Release Profile of Praziquantel as a Strategy for Controlling Drug Release},
journal = {ACS Applied Nano Materials},
year = {2024},
volume = {7},
number = {3},
pages = {2417--2429},
doi = {10.1021/acsanm.3c06099}
}
EUVIMED